Analog-based Approaches to Isolation of Aptamers for Challenging Targets
基于模拟的方法来分离具有挑战性的靶标的适体
基本信息
- 批准号:10429939
- 负责人:
- 金额:$ 57.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-01 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:Academic Medical CentersAddressAffinityAlanineAlgorithmsAnimal ModelBindingBiological AssayBiological MarkersCalcifediolChargeCholecalciferolClinicalClinical ChemistryCocaineComplexCyclosporineDevicesDominant-Negative MutationDrug MonitoringElementsEpitopesFailureFree EnergyGenerationsGrantHealthHomeHydrophobic SurfacesHydrophobicityImmunosuppressive AgentsIndividualLaboratoriesLibrariesMeasurementMeasuresMedicalMethodsMolecularMonitorNucleic AcidsOligonucleotidesOutcomePatientsPharmaceutical ChemistryPhenylalanineProceduresProcessProtocols documentationPublishingRoleSDZ RADSamplingSchemeSerotoninShapesSirolimusSolubilitySpecificityStructureTacrolimusTestingTherapeuticTimeTobramycinUreaValidationValproic AcidVancomycinVoriconazoleaddictionanalogaptamerbaseclinical applicationclinical decision-makingdesignfunctional groupinsightnext generationpoint of carepreventprogramsrapid testreceptorresearch clinical testingsensorsmall moleculevalproate
项目摘要
Summary
Aptamers (oligonucleotide-based receptors) are potentially general go-to receptors for precise and accurate,
yet rapid, determination of small molecules in clinical chemistry. The systematic improvement of methods to
develop high-quality aptamers for small molecules recently led to isolation of multiple outstanding aptamers
that are currently being integrated in the next generation of tests for at home, real-time, and clinical laboratory
(automatized, parallel) analysis. For example, at Columbia University Medical Center (CUMC), we are at a
critical junction with original aptamers for phenyl alanine, vancomycin, tobramycin, and urea, all being in the
process of validation on actual patients’ samples in the context of their role in assays for clinical decision-
making. Further, our collaborators are testing fourth generation cocaine aptamers in conjunction with our
published serotonin aptamers in animal models of addiction.
Despite these advances, and with over 100 successful selections behind us, there were important individual
targets and even whole classes of targets, for which multiple attempts to isolate aptamers with even minimal
affinity, failed unexpectedly. We now present what we learned from these failures and describe a systematic
approach to isolate clinically useful aptamers for even the most challenging targets. In the process, we
introduce conceptually new selections, including ‘isostere-’, ‘analog-’, and ‘bait-and-switch’ selections. .
Through three Aims, we will develop algorithms for selection of clinically useful aptamers to challenging
analytes. We will pursue: (1) Complex targets with solubility below that needed to capture even low-affinity
aptamers (voriconazole and 25-OH vitamin D3); (2) Anionic targets with low binding free energy to aptamers
isolated from small oligonucleotide libraries (valproic acid); and (3) Immunosuppressants that require either
large, or extended and shallow binding pockets (cyclosporine and sirolimus, its analog everolimus, all
hydrophobic, large, and with poor epitopes). Newly isolated aptamers will be continuously optimized to reach
affinities required for clinical testing, turned into appropriate sensor formats, and validated as if we are
preparing a laboratory-developed test (LDT) for submission to the NYS Department of Health.
Beyond specific receptors for high-value targets, the important outcome of this grant will not be individual rapid
procedures as it had been standard in the field, but algorithms for multistep implementation of protocols. The
substantial increase in effort over standard practice is fully justified by solving widely recognized problems in
clinical chemistry: enabling quantification of analytes for which there are no rapid assays with sufficient
accuracy and precision for clinical decision making and frequent at ‘point-of-need’ monitoring.
摘要
适配子(基于寡核苷酸的受体)是潜在的通用Go-to受体,
然而,在临床化学中,小分子的快速测定。方法的系统改进
开发高质量的小分子适配子最近导致分离出多个优秀的适配子
目前正在集成到家庭、实时和临床实验室的下一代测试中
(自动化、并行)分析。例如,在哥伦比亚大学医学中心(CUMC),我们处于
与苯丙氨酸、万古霉素、妥布霉素和尿素的原始适配子的关键连接,都在
根据实际患者样本在临床决策分析中的作用对其进行验证的过程-
制作。此外,我们的合作者正在测试第四代可卡因适体,与我们的
公布了成瘾动物模型中的5-羟色胺适配子。
尽管取得了这些进步,在我们身后有100多个成功的选择,但还是有一些重要的个人
靶标,甚至整个类别的靶标,对于这些靶标,多次尝试分离适配子,即使是最少的
亲和力,竟然失败了。我们现在介绍我们从这些失败中学到的东西,并描述一个系统的
为即使是最具挑战性的靶点分离临床上有用的适配子的方法。在这个过程中,我们
在概念上引入新的选择,包括‘isstere-’、‘模拟-’和‘诱饵和切换’选择。。
通过三个目标,我们将开发算法来选择临床上有用的适体来挑战
分析物。我们将追求:(1)溶解度低于捕捉低亲和力所需的复杂靶标
适配子(伏立康唑和25-羟基维生素D3);(2)与适配子结合能低的阴离子靶标
从小的寡核苷酸文库分离(丙戊酸);和(3)需要以下两种之一的免疫抑制剂
大的或延长的浅绑扎袋(环孢素A和西罗莫司,其类似物伊维莫司,所有
疏水性、大和表位差)。新分离的适配子将不断优化,以达到
临床测试所需的亲和力,转换为适当的传感器格式,并进行验证,就像我们
准备实验室开发的测试(LDT),以提交给纽约卫生部。
除了高价值靶标的特定受体外,这项拨款的重要结果不会是个别迅速的。
程序,因为它一直是该领域的标准,但多步骤执行协议的算法。这个
在标准实践上大幅增加的努力是完全合理的,因为解决了
临床化学:能够对没有快速分析的分析物进行量化
确保临床决策的准确性和精确性,并经常在“需要时”进行监测。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Milan N Stojanovic其他文献
Milan N Stojanovic的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Milan N Stojanovic', 18)}}的其他基金
Analog-based Approaches to Isolation of Aptamers for Challenging Targets
基于模拟的方法来分离具有挑战性的靶标的适体
- 批准号:
10388660 - 财政年份:2020
- 资助金额:
$ 57.2万 - 项目类别:
Analog-based Approaches to Isolation of Aptamers for Challenging Targets
基于模拟的方法来分离具有挑战性的靶标的适体
- 批准号:
10647742 - 财政年份:2020
- 资助金额:
$ 57.2万 - 项目类别:
Analog-based Approaches to Isolation of Aptamers for Challenging Targets
基于模拟的方法来分离具有挑战性的靶标的适体
- 批准号:
10795432 - 财政年份:2020
- 资助金额:
$ 57.2万 - 项目类别:
Analog-based Approaches to Isolation of Aptamers for Challenging Targets
基于模拟的方法来分离具有挑战性的靶标的适体
- 批准号:
10190976 - 财政年份:2020
- 资助金额:
$ 57.2万 - 项目类别:
Analog-based Approaches to Isolation of Aptamers for Challenging Targets
基于模拟的方法来分离具有挑战性的靶标的适体
- 批准号:
10033063 - 财政年份:2020
- 资助金额:
$ 57.2万 - 项目类别:
Automated Microfluidic Selection of Aptamers against Carbohydrates
针对碳水化合物的适配体的自动微流体选择
- 批准号:
8985077 - 财政年份:2015
- 资助金额:
$ 57.2万 - 项目类别:
Isolation of narrow subpopulations of cells using molecular computing cascades
使用分子计算级联分离狭窄的细胞亚群
- 批准号:
8302751 - 财政年份:2012
- 资助金额:
$ 57.2万 - 项目类别:
Theranostic Nano-objects: Basic Principles and Initial Applications
治疗诊断纳米物体:基本原理和初步应用
- 批准号:
8730687 - 财政年份:2012
- 资助金额:
$ 57.2万 - 项目类别:
Theranostic Nano-objects: Basic Principles and Initial Applications
治疗诊断纳米物体:基本原理和初步应用
- 批准号:
8411867 - 财政年份:2012
- 资助金额:
$ 57.2万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 57.2万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 57.2万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 57.2万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 57.2万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 57.2万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 57.2万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 57.2万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 57.2万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 57.2万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 57.2万 - 项目类别:
Research Grant